Quest Diagnostics Inc Proceeds from Divestiture of Businesses
Quest Diagnostics Inc (DGX) reported Proceeds from Divestiture of Businesses of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2020-02-20
- Quest Diagnostics Inc proceeds from divestiture of businesses for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Quest Diagnostics Inc proceeds from divestiture of businesses for the quarter ending 2017-09-30 was $0.00.
- Quest Diagnostics Inc proceeds from divestiture of businesses for the quarter ending 2016-12-31 was $25.00M.
- Quest Diagnostics Inc proceeds from divestiture of businesses for the quarter ending 2016-09-30 was -$5.00M.
- Quest Diagnostics Inc proceeds from divestiture of businesses for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Quest Diagnostics Inc proceeds from divestiture of businesses for fiscal 2018 was $2.00M, a 100.00% increase from fiscal 2017.
- Quest Diagnostics Inc proceeds from divestiture of businesses for fiscal 2017 was $1.00M, a 99.66% decline from fiscal 2016.
- Quest Diagnostics Inc proceeds from divestiture of businesses for fiscal 2016 was $295.00M.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 6 month as first filed | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 9 month as first filed | Proceeds from Divestiture of Businesses 12 month | Proceeds from Divestiture of Businesses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-20 | ||||||
| 2018-12-31 | $2.00M 10-K · filed 2020-02-20 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 derived: sum of 2 quarters · filed 2020-02-20 | $1.00M 10-K · filed 2020-02-20 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $1.00M 10-Q · filed 2017-10-19 | |||||
| 2017-06-30 | $1.00M 10-Q · filed 2017-07-25 | ||||||
| 2016-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $20.00M derived: sum of 2 quarters · filed 2019-02-21 | $295.00M 10-K · filed 2019-02-21 | $270.00M 10-K · filed 2017-02-22 | |||
| 2016-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $270.00M 10-Q · filed 2017-10-19 | |||||
| 2016-06-30 | $275.00M 10-Q · filed 2017-07-25 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $0.00 derived: sum of 2 quarters · filed 2018-02-23 | $0.00 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-21 | $0.00 10-Q · filed 2016-10-21 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2016-07-25 | ||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $0.00 derived: sum of 2 quarters · filed 2017-02-22 | $0.00 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | |||||
| 2014-06-30 | $0.00 10-Q · filed 2014-07-31 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $30.00M derived: sum of 2 quarters · filed 2016-02-26 | $296.00M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $296.00M 10-Q · filed 2014-10-30 | $296.33M 10-Q · filed 2013-10-24 | ||||
| 2013-06-30 | $266.00M 10-Q · filed 2014-07-31 | $266.04M 10-Q · filed 2013-07-25 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $0.00 10-Q · filed 2013-10-24 | |||||
| 2012-06-30 | $0.00 10-Q · filed 2013-07-25 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |